As of Oct 24
| 0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 13.00, with a high estimate of 17.00 and a low estimate of 12.00. The median estimate represents a +10.26% increase from the last price of 11.79.
The current consensus among 7 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.